Many legal experts attribute skyrocketing pro se filings to artificial intelligence tools, but some judges in federal and ...
Tempus, a technology company leading the adoption of AI to advance precision medicine, today highlighted results of the Articulate Pro study, published in Nature Digital Medicine, evaluating the use ...
The rapid expansion of complex biotherapeutic modalities such as RNA-based therapies is pushing conventional LC–MS workflows beyond their limits. Even though there has been great progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results